Phantom Neuro, the first-of-its-kind neurotech startup that delivers a low power, high accuracy system for lifelike control of robotic orthopedic technologies, today announced a $6 million funding round led by new investor Time Bioventures.
Read MoreTime BioVentures is thrilled to announce its investment in BillionToOne's $125M Series C round, joining co-lead investors Adams Street Partners and Hummingbird Ventures, as well as a syndicate including Baillie Gifford, Neotribe Ventures, Norwest Venture Partners, Civilization Ventures, Fifty Years VC, Pacific 8 Ventures, and Libertus Capital.
Read More“Invest Like The Best” podcast - D.A. on Investing in Healthcare
Read MoreTime BioVentures Invests in NanoMosaic's $40M Series A Round
Read MoreBIOS Interview with Tim & D.A.
Read MoreD.A. Wallach & George Church in Conversation
Read MoreTime BioVentures Invests in DeepSight Technology's $25M Series A Round
Read MoreTime BioVentures joins Obvious Ventures, Eli Lilly, and Johnson & Johnson Innovation in Iterative Scopes' $30M Series A Round
Read MoreTime BioVentures Invests in Neuralink's $205M Series C Financing
Read MoreTime BioVentures Invests in Iterative Scopes
Read MoreThe Paradox of Pricing pt. 1: Drugs by D.A. Wallach
Read More
